Dapagliflozin propanediol
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
748 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 33 | 22 | 83 | 103 | 56 | 290 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 11 | 14 | 56 | 61 | 32 | 168 |
| Heart failure | D006333 | EFO_0003144 | I50 | 5 | 20 | 25 | 35 | 35 | 113 |
| Chronic renal insufficiency | D051436 | — | N18 | 4 | 21 | 14 | 14 | 15 | 64 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | 2 | 16 | 12 | 10 | 10 | 46 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 6 | 8 | 10 | 11 | 4 | 37 |
| Hypertension | D006973 | EFO_0000537 | I10 | 3 | 3 | 7 | 4 | 5 | 21 |
| Myocardial infarction | D009203 | EFO_0000612 | I21 | — | 2 | 6 | 4 | 7 | 18 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | 1 | 3 | 8 | 7 | 18 |
| Infarction | D007238 | EFO_0009463 | — | — | 1 | 6 | 3 | 6 | 15 |
Show 111 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Retinal diseases | D012164 | — | H35.9 | — | 1 | 2 | — | 2 | 5 |
| Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | — | — | 4 | — | — | 4 |
| Sleep apnea syndromes | D012891 | EFO_0003877 | G47.3 | — | 1 | 1 | — | 1 | 3 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | 2 | 2 | — | — | 3 |
| Sepsis | D018805 | EFO_0001420 | A41.9 | — | — | 1 | — | 2 | 3 |
| Cognitive dysfunction | D060825 | — | G31.84 | — | 1 | 1 | — | 2 | 3 |
| Ischemic stroke | D000083242 | — | — | — | 1 | 2 | — | 1 | 3 |
| Endocrine system diseases | D004700 | EFO_0001379 | E34.9 | — | — | 3 | — | — | 3 |
| Ascites | D001201 | — | R18 | — | 3 | 1 | — | — | 3 |
| Catheter ablation | D017115 | — | — | 1 | 1 | 1 | — | — | 2 |
Show 40 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | 3 | — | — | 1 | 4 |
| Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | 1 | 3 |
| Pulmonary arterial hypertension | D000081029 | — | — | — | 1 | — | — | 1 | 2 |
| Edema | D004487 | — | R60.9 | — | 1 | — | — | 1 | 2 |
| Cystinuria | D003555 | — | E72.01 | — | 2 | — | — | — | 2 |
| Prostatic neoplasms | D011471 | — | C61 | 1 | 1 | — | — | — | 2 |
| Triple negative breast neoplasms | D064726 | — | — | 1 | 1 | — | — | — | 2 |
| Alcoholic fatty liver | D005235 | — | K70.0 | — | 1 | — | — | 1 | 2 |
| Amyloidosis | D000686 | EFO_1001875 | E85 | — | 1 | — | — | 1 | 2 |
| Depression | D003863 | — | F33.9 | 1 | 2 | — | — | — | 2 |
Show 29 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 28 | — | — | — | 1 | 29 |
| Diabetic ketoacidosis | D016883 | EFO_1000897 | — | 1 | — | — | — | 3 | 4 |
| Lung neoplasms | D008175 | — | C34.90 | 1 | — | — | — | 1 | 2 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | — | — | — | — | 1 |
| Therapeutic equivalency | D013810 | — | — | 1 | — | — | — | — | 1 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | 1 | — | — | — | — | 1 |
| Reperfusion injury | D015427 | — | — | 1 | — | — | — | — | 1 |
| Vascular ring | D000073872 | — | Q25.45 | 1 | — | — | — | — | 1 |
| Hyperinsulinism | D006946 | — | E16.1 | 1 | — | — | — | — | 1 |
| Hypothyroidism | D007037 | EFO_0004705 | E03.9 | 1 | — | — | — | — | 1 |
Show 3 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Urinary tract infections | D014552 | EFO_0003103 | N39.0 | — | — | — | — | 4 | 4 |
| Infections | D007239 | EFO_0000544 | — | — | — | — | — | 3 | 3 |
| Hemorrhage | D006470 | MP_0001914 | R58 | — | — | — | — | 1 | 1 |
| Coronavirus infections | D018352 | EFO_0007224 | B34.2 | — | — | — | — | 1 | 1 |
| Menorrhagia | D008595 | EFO_0003945 | N92.0 | — | — | — | — | 1 | 1 |
| Hemophilia a | D006467 | EFO_0007267 | D66 | — | — | — | — | 1 | 1 |
| Pain | D010146 | EFO_0003843 | R52 | — | — | — | — | 1 | 1 |
| Down syndrome | D004314 | EFO_0001064 | Q90 | — | — | — | — | 1 | 1 |
| Pneumonia | D011014 | EFO_0003106 | J18 | — | — | — | — | 1 | 1 |
| Mucocutaneous lymph node syndrome | D009080 | EFO_0004246 | M30.3 | — | — | — | — | 1 | 1 |
Show 33 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
20,645 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use